Medicare and Medicaid Programs: Application From the Accreditation Commission for Health Care, Inc. for Continued Approval of Its End-Stage Renal Disease (ESRD) Accreditation Program, 16981-16983 [2023-05761]

Download as PDF Federal Register / Vol. 88, No. 54 / Tuesday, March 21, 2023 / Notices that the use of non-compete agreements has a tendency to harm competition and workers, but fails to provide facts to support the hypothesized outcome. Similar to the Commission’s complaints against O–I Glass and Ardagh Group, the complaint against Anchor Glass suffers from several omissions. It does not allege that the company’s noncompete provisions are unreasonable based on their temporal length, subject matter, or geographic scope; neither does it allege that the non-compete clauses were enforced. The complaint does not make factual allegations regarding the inability of a competing rival in the glass container industry to enter or expand. While the complaint alleges that the non-compete clauses reduce employee mobility, thereby leading to lower wages, reduced benefits, and less favorable working conditions, the complaint does not identify a relevant market for particular types of labor and fails to allege a market effect on wages or other terms of employment. For the reasons outlined here and explained in detail in my January 2023 statement, I dissent. [FR Doc. 2023–05701 Filed 3–20–23; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket No. CDC–2022–0044] CDC Recommendations for Hepatitis B Screening and Testing—United States, 2022 Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: General notice. AGENCY: The Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS), announces the availability of the final CDC Recommendations for Hepatitis B Screening and Testing—United States, 2022. DATES: The final document was published as an MMWR Reports & Recommendations on March 10, 2023. ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: ftc_gov/pdf/p221202sec5enforcementpolicy statement_002.pdf; Christine S. Wilson, Dissenting Statement Regarding the ‘‘Policy Statement Regarding the Scope of Unfair Methods of Competition Under Section 5 of the Federal Trade Commission Act’’ (Nov. 10, 2022), https:// www.ftc.gov/system/files/ftc_gov/pdf/ P221202Section5PolicyWilsonDissentStmt.pdf. VerDate Sep<11>2014 19:23 Mar 20, 2023 Jkt 259001 The document may be found in the docket at www.regulations.gov, Docket No. CDC– 2022–0044 and at https://www.cdc.gov/ mmwr/volumes/72/rr/rr7201a1.htm?s_ cid=rr7201a1_w. FOR FURTHER INFORMATION CONTACT: Erin Conners, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop U12–3, Atlanta, GA 30329. Telephone: 404–639–8000; Email: DVHpolicy@cdc.gov. SUPPLEMENTARY INFORMATION: In 2022, CDC determined that CDC Recommendations for Hepatitis B Screening and Testing—United States, 2022 constituted influential scientific information (ISI) that will have a clear and substantial impact on important public policies and private sector decisions. Under the Information Quality Act, Public Law 106–554, federal agencies are required to conduct peer review of the information by specialists in the field who were not involved in the development of these recommendations. CDC solicited nominations for reviewers from the American Association for the Study of Liver Diseases (AASLD), Infectious Diseases Society of America (IDSA) and American College of Physicians (ACP). Five clinicians with expertise in hepatology, gastroenterology, internal medicine, infectious diseases, and/or pediatrics provided structured peer reviews. A list of peer reviewers and CDC’s responses to peer review comments are available at CDC’s Viral Hepatitis Influential Scientific Information web page at https:// www.cdc.gov/hepatitis/policy/isireview/ index.htm. In addition, on April 4, 2022, CDC published a notice in the Federal Register (87 FR 19516–19517) to obtain public comment on the draft recommendations for hepatitis B screening and testing. The comment period closed on June 3, 2022. CDC received comments from 28 commenters on the draft recommendations document. Public commenters included those from academia, the health care sector, advocacy groups, professional organizations, industry, the public, and a consulting group. Many of the comments expressed support for the recommendations. Other comments related to the 3-panel test recommendation, inclusion of hepatitis D information, the hepatitis B prevalence estimate, modifying testing and vaccination language, adding scientific references, and making other minor language modifications. CDC addressed these comments by correcting, clarifying, or updating ADDRESSES: PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 16981 content in the final recommendations. A summary of public comments and CDC’s response can be found in the Documents tab of the docket. Tiffany Brown, Acting Executive Secretary, Centers for Disease Control and Prevention. [FR Doc. 2023–05715 Filed 3–20–23; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–3434–FN] Medicare and Medicaid Programs: Application From the Accreditation Commission for Health Care, Inc. for Continued Approval of Its End-Stage Renal Disease (ESRD) Accreditation Program Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice. AGENCY: This final notice announces our decision to approve the Accreditation Commission for Health Care, Inc for continued recognition as a national accrediting organization for end stage renal disease facilities that wish to participate in the Medicare or Medicaid programs. DATES: The decision announced in this final notice is applicable on April 11, 2023 through April 10, 2029. FOR FURTHER INFORMATION CONTACT: Joy Webb, (410) 786–1667. Caecilia Blondiaux, (410) 786–2190. SUPPLEMENTARY INFORMATION: SUMMARY: I. Background Under the Medicare program, eligible beneficiaries may receive covered services from an end stage renal disease (ESRD) facility provided certain requirements are met. Section 1881(b) of the Social Security Act (the Act), establishes distinct criteria for facilities seeking designation as an ESRD facility. Regulations concerning provider agreements are at 42 CFR part 489 and those pertaining to activities relating to the survey and certification of facilities are at 42 CFR part 488. The regulations at 42 CFR part 494 specify the minimum conditions that an ESRD facility must meet to participate in the Medicare program. Generally, to enter into an agreement, an ESRD facility must first be certified by a state survey agency (SA) as complying with the conditions or requirements set forth in part 494 of our E:\FR\FM\21MRN1.SGM 21MRN1 16982 Federal Register / Vol. 88, No. 54 / Tuesday, March 21, 2023 / Notices ddrumheller on DSK120RN23PROD with NOTICES1 regulations. Thereafter, the ESRD facility is subject to regular surveys by a SA to determine whether it continues to meet these requirements. Section 1865(a)(1) of the Act provides that, if a provider entity demonstrates through accreditation by a Centers for Medicare & Medicaid Services (CMS)approved national accrediting organization (AO) that all applicable Medicare requirements are met or exceeded, we will deem those provider entities as having met such requirements. Accreditation by an AO is voluntary and is not required for Medicare participation. If an AO is recognized by the Secretary of the Department of Health and Human Services (the Secretary) as having standards for accreditation that meet or exceed Medicare requirements, any provider entity accredited by the national accrediting body’s approved program would be deemed to meet the Medicare conditions. A national AO applying for approval of its accreditation program under part 488, subpart A, must provide CMS with reasonable assurance that the AO requires the accredited provider entities to meet requirements that are at least as stringent as the Medicare conditions. Our regulations concerning the approval of AOs are set forth at §§ 488.4, 488.5 and 488.5(e)(2)(i). The regulations at § 488.5(e)(2)(i) require AOs to reapply for continued approval of its accreditation program every 6 years or sooner, as determined by CMS. ACHC’s current term of approval for their ESRD facility accreditation program expires April 11, 2023. II. Application Approval Process Section 1865(a)(3)(A) of the Act provides a statutory timetable to ensure that our review of applications for CMSapproval of an accreditation program is conducted in a timely manner. The Act provides us 210 days after the date of receipt of a complete application, with any documentation necessary to make the determination, to complete our survey activities and application process. Within 60 days after receiving a complete application, we must publish a notice in the Federal Register that identifies the national accrediting body making the request, describes the request, and provides no less than a 30day public comment period. At the end of the 210-day period, we must publish a notice in the Federal Register approving or denying the application. III. Provisions of the Proposed Notice On October 4, 2022, we published a proposed notice in the Federal Register (87 FR 60171), announcing ACHC’s VerDate Sep<11>2014 19:23 Mar 20, 2023 Jkt 259001 request for continued approval of its Medicare ESRD facility accreditation program. In the October 4, 2022 proposed notice, we detailed our evaluation criteria. Under section 1865(a)(2) of the Act and in our regulations at § 488.5, we conducted a review of ACHC’s Medicare ESRD facility accreditation application in accordance with the criteria specified by our regulations, which include, but are not limited to the following: • A virtual onsite administrative review of ACHC’s: (1) corporate policies; (2) financial and human resources available to accomplish the proposed surveys; (3) procedures for training, monitoring, and evaluation of its ESRD surveyors; (4) ability to investigate and respond appropriately to complaints against accredited ESRD facilities; and (5) survey review and decision-making process for accreditation. • The comparison of ACHC’s Medicare ESRD facility accreditation program standards to our current Medicare ESRD facility conditions of participation (CoPs). • A documentation review of ACHC’s survey process to do the following: ++ Determine the composition of the survey team, surveyor qualifications, and ACHC’s ability to provide continuing surveyor training. ++ Compare ACHC’s processes to those we require of state survey agencies, including periodic resurvey and the ability to investigate and respond appropriately to complaints against ACHC accredited ESRD facilities. ++ Evaluate ACHC’s procedures for monitoring accredited ESRD facilities it has found to be out of compliance with ACHC’s program requirements. (This pertains only to monitoring procedures when ACHC identifies non-compliance. If noncompliance is identified by a SA through a validation survey, the SA monitors corrections as specified at § 488.9(c)). ++ Assess ACHC’s ability to report deficiencies to the surveyed ESRD facilities and respond to the ESRD facilities’ plans of correction in a timely manner. ++ Establish ACHC’s ability to provide CMS with electronic data and reports necessary for effective validation and assessment of the organization’s survey process. ++ Determine the adequacy of ACHC’s staff and other resources. ++ Confirm ACHC’s ability to provide adequate funding for performing required surveys. ++ Confirm ACHC’s policies with respect to surveys being unannounced. PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 ++ Confirm ACHC’s policies and procedures to avoid conflicts of interest, including the appearance of conflicts of interest, involving individuals who conduct surveys or participate in accreditation decisions. ++ Obtain ACHC’s agreement to provide CMS with a copy of the most current accreditation survey together with any other information related to the survey as we may require, including corrective action plans. IV. Analysis of and Responses to Public Comments on the Proposed Notice In accordance with section 1865(a)(3)(A) of the Act, the October 4, 2022 proposed notice also solicited public comments regarding whether ACHC’s requirements met or exceeded the Medicare CoPs for ESRD facilities. No comments were received in response to our proposed notice. V. Provisions of the Final Notice A. Differences Between ACHC’s Standards and Requirements for Accreditation and Medicare Conditions and Survey Requirements We compared ACHC’s ESRD facility accreditation requirements and survey process with the Medicare CoPs of parts 494, and the survey and certification process requirements of parts 488 and 489. Our review and evaluation of ACHC’s ESRD facility accreditation application, which were conducted as described in section III. of this final notice, yielded the following areas where, as of the date of this final notice, ACHC has completed revising its standards and certification processes in order to— • Meet the standard’s requirements of all of the following regulations: ++ Section 494.30(b)(3)(x), to clarify and address the contingency plans for staff who are not fully vaccinated for COVID–19. ++ Section 494.60(d)(1), to address dialysis facilities that do not provide one or more exits to the outside must comply with Life Safety Code (NFPA 101). ++ Section 494.60(d)(4), to clarify specific Life Safety Code provisions that may be waived, only if the waiver will not adversely affect the health and safety of the patients. ++ Section 494.60(d)(5), to clarify that no dialysis facility may operate in a building adjacent to an industrial high hazard area. In addition to the standards review, CMS also reviewed ACHC’s comparable survey processes, which were conducted as described in section III. of this final notice, and yielded the E:\FR\FM\21MRN1.SGM 21MRN1 Federal Register / Vol. 88, No. 54 / Tuesday, March 21, 2023 / Notices following areas where, as of the date of this final notice, ACHC has completed revising its survey processes in order to demonstrate that it uses survey processes that are comparable to state survey agency processes by: ++ Revising the compliant policies and processes to align with the State Operations Manual, Chapter 5 guidance. In particular, the Administrative Review Offsite Investigation process to align with the triage process to track and trend for potential focus areas during the next onsite survey or complete an onsite complaint investigation. ++ Clarifying the quantifying data surrounding equipment and maintenance logs, specifically the equipment review. The survey reports or notes need to identify the number of logs reviewed, date or timeframes. ++ Providing surveyor training on documentation reviews and the process for verifying the completeness of the facility request. ++ Reinforcing and providing education to facility surveyors to request Dialysis Facility Reports, the reports provide aggregate data regarding laboratory values, demographic information, mortality rates, hospitalizations, infections, etc., which may assist the surveyors during the review of patient medical records. ++ Developing additional surveyor training for verifying all elements required for the CMS emergency preparedness requirements. ddrumheller on DSK120RN23PROD with NOTICES1 Based on our review and observations described in section III. and section V. of this final notice, we approve ACHC as a national accreditation organization for ESRD facilities that request participation in the Medicare program. The decision announced in this final notice is effective April 11, 2023 through April 11, 2029 (6 years). In accordance with § 488.5(e)(2)(i) the term of the approval will not exceed 6 years. While ACHC has taken actions based on the findings annotated in section V.A., of this final notice, (Differences Between ACHC’s Standards and Requirements for Accreditation and Medicare Conditions and Survey Requirements) as authorized under § 488.8, we will continue ongoing review of ACHC’s ESRD survey substance and processes. In keeping with CMS’s initiative to increase AO oversight broadly, and ensure that our requested revisions by ACHC are completed, CMS expects more frequent review of ACHC’s activities in the future. 19:23 Mar 20, 2023 This document does not impose information collection requirements, that is, reporting, recordkeeping or third-party disclosure requirements. Consequently, there is no need for review by the Office of Management and Budget under the authority of the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.) The Administrator of the Centers for Medicare & Medicaid Services (CMS), Chiquita Brooks-LaSure, having reviewed and approved this document, authorizes Evell J.Barco Holland, who is the Federal Register Liaison, to electronically sign this document for purposes of publication in the Federal Register. Dated: March 15, 2023. Evell J. Barco Holland, Federal Register Liaison, Center for Medicare & Medicaid Services. [FR Doc. 2023–05761 Filed 3–20–23; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifiers: CMS–10847] Agency Information Collection Activities: Proposed Collection; Comment Request Jkt 259001 collection techniques or other forms of information technology to minimize the information collection burden. DATES: Comments must be received by May 22, 2023. ADDRESSES: When commenting, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in any one of the following ways: 1. Electronically. You may send your comments electronically to https:// www.regulations.gov. Follow the instructions for ‘‘Comment or Submission’’ or ‘‘More Search Options’’ to find the information collection document(s) that are accepting comments. 2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention: Document Identifier/OMB Control Number: ll, Room C4–26–05, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, please access the CMS PRA website by copying and pasting the following web address into your web browser: https://www.cms.gov/ Regulations-and-Guidance/Legislation/ PaperworkReductionActof1995/PRAListing. FOR FURTHER INFORMATION CONTACT: Centers for Medicare & Medicaid Services, Health and Human Services (HHS). ACTION: Notice. Contents The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (the PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated This notice sets out a summary of the use and burden associated with the following information collections. More detailed information can be found in each collection’s supporting statement and associated materials (see ADDRESSES). CMS–10847 Information Collection Request for Negotiation Data Elements under Sections 11001 and 11002 of the Inflation Reduction Act Under the PRA (44 U.S.C. 3501– 3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term ‘‘collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA requires federal agencies to publish a AGENCY: B. Term of Approval VerDate Sep<11>2014 VI. Collection of Information Requirements 16983 SUMMARY: PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 William N. Parham at (410) 786–4669. SUPPLEMENTARY INFORMATION: E:\FR\FM\21MRN1.SGM 21MRN1

Agencies

[Federal Register Volume 88, Number 54 (Tuesday, March 21, 2023)]
[Notices]
[Pages 16981-16983]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-05761]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[CMS-3434-FN]


Medicare and Medicaid Programs: Application From the 
Accreditation Commission for Health Care, Inc. for Continued Approval 
of Its End-Stage Renal Disease (ESRD) Accreditation Program

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This final notice announces our decision to approve the 
Accreditation Commission for Health Care, Inc for continued recognition 
as a national accrediting organization for end stage renal disease 
facilities that wish to participate in the Medicare or Medicaid 
programs.

DATES: The decision announced in this final notice is applicable on 
April 11, 2023 through April 10, 2029.

FOR FURTHER INFORMATION CONTACT: 
    Joy Webb, (410) 786-1667.
    Caecilia Blondiaux, (410) 786-2190.

SUPPLEMENTARY INFORMATION:

I. Background

    Under the Medicare program, eligible beneficiaries may receive 
covered services from an end stage renal disease (ESRD) facility 
provided certain requirements are met. Section 1881(b) of the Social 
Security Act (the Act), establishes distinct criteria for facilities 
seeking designation as an ESRD facility. Regulations concerning 
provider agreements are at 42 CFR part 489 and those pertaining to 
activities relating to the survey and certification of facilities are 
at 42 CFR part 488. The regulations at 42 CFR part 494 specify the 
minimum conditions that an ESRD facility must meet to participate in 
the Medicare program.
    Generally, to enter into an agreement, an ESRD facility must first 
be certified by a state survey agency (SA) as complying with the 
conditions or requirements set forth in part 494 of our

[[Page 16982]]

regulations. Thereafter, the ESRD facility is subject to regular 
surveys by a SA to determine whether it continues to meet these 
requirements.
    Section 1865(a)(1) of the Act provides that, if a provider entity 
demonstrates through accreditation by a Centers for Medicare & Medicaid 
Services (CMS)-approved national accrediting organization (AO) that all 
applicable Medicare requirements are met or exceeded, we will deem 
those provider entities as having met such requirements. Accreditation 
by an AO is voluntary and is not required for Medicare participation.
    If an AO is recognized by the Secretary of the Department of Health 
and Human Services (the Secretary) as having standards for 
accreditation that meet or exceed Medicare requirements, any provider 
entity accredited by the national accrediting body's approved program 
would be deemed to meet the Medicare conditions. A national AO applying 
for approval of its accreditation program under part 488, subpart A, 
must provide CMS with reasonable assurance that the AO requires the 
accredited provider entities to meet requirements that are at least as 
stringent as the Medicare conditions. Our regulations concerning the 
approval of AOs are set forth at Sec. Sec.  488.4, 488.5 and 
488.5(e)(2)(i). The regulations at Sec.  488.5(e)(2)(i) require AOs to 
reapply for continued approval of its accreditation program every 6 
years or sooner, as determined by CMS.
    ACHC's current term of approval for their ESRD facility 
accreditation program expires April 11, 2023.

II. Application Approval Process

    Section 1865(a)(3)(A) of the Act provides a statutory timetable to 
ensure that our review of applications for CMS-approval of an 
accreditation program is conducted in a timely manner. The Act provides 
us 210 days after the date of receipt of a complete application, with 
any documentation necessary to make the determination, to complete our 
survey activities and application process. Within 60 days after 
receiving a complete application, we must publish a notice in the 
Federal Register that identifies the national accrediting body making 
the request, describes the request, and provides no less than a 30-day 
public comment period. At the end of the 210-day period, we must 
publish a notice in the Federal Register approving or denying the 
application.

III. Provisions of the Proposed Notice

    On October 4, 2022, we published a proposed notice in the Federal 
Register (87 FR 60171), announcing ACHC's request for continued 
approval of its Medicare ESRD facility accreditation program. In the 
October 4, 2022 proposed notice, we detailed our evaluation criteria. 
Under section 1865(a)(2) of the Act and in our regulations at Sec.  
488.5, we conducted a review of ACHC's Medicare ESRD facility 
accreditation application in accordance with the criteria specified by 
our regulations, which include, but are not limited to the following:
     A virtual onsite administrative review of ACHC's: (1) 
corporate policies; (2) financial and human resources available to 
accomplish the proposed surveys; (3) procedures for training, 
monitoring, and evaluation of its ESRD surveyors; (4) ability to 
investigate and respond appropriately to complaints against accredited 
ESRD facilities; and (5) survey review and decision-making process for 
accreditation.
     The comparison of ACHC's Medicare ESRD facility 
accreditation program standards to our current Medicare ESRD facility 
conditions of participation (CoPs).
     A documentation review of ACHC's survey process to do the 
following:
    ++ Determine the composition of the survey team, surveyor 
qualifications, and ACHC's ability to provide continuing surveyor 
training.
    ++ Compare ACHC's processes to those we require of state survey 
agencies, including periodic resurvey and the ability to investigate 
and respond appropriately to complaints against ACHC accredited ESRD 
facilities.
    ++ Evaluate ACHC's procedures for monitoring accredited ESRD 
facilities it has found to be out of compliance with ACHC's program 
requirements. (This pertains only to monitoring procedures when ACHC 
identifies non-compliance. If noncompliance is identified by a SA 
through a validation survey, the SA monitors corrections as specified 
at Sec.  488.9(c)).
    ++ Assess ACHC's ability to report deficiencies to the surveyed 
ESRD facilities and respond to the ESRD facilities' plans of correction 
in a timely manner.
    ++ Establish ACHC's ability to provide CMS with electronic data and 
reports necessary for effective validation and assessment of the 
organization's survey process.
    ++ Determine the adequacy of ACHC's staff and other resources.
    ++ Confirm ACHC's ability to provide adequate funding for 
performing required surveys.
    ++ Confirm ACHC's policies with respect to surveys being 
unannounced.
    ++ Confirm ACHC's policies and procedures to avoid conflicts of 
interest, including the appearance of conflicts of interest, involving 
individuals who conduct surveys or participate in accreditation 
decisions.
    ++ Obtain ACHC's agreement to provide CMS with a copy of the most 
current accreditation survey together with any other information 
related to the survey as we may require, including corrective action 
plans.

IV. Analysis of and Responses to Public Comments on the Proposed Notice

    In accordance with section 1865(a)(3)(A) of the Act, the October 4, 
2022 proposed notice also solicited public comments regarding whether 
ACHC's requirements met or exceeded the Medicare CoPs for ESRD 
facilities. No comments were received in response to our proposed 
notice.

V. Provisions of the Final Notice

A. Differences Between ACHC's Standards and Requirements for 
Accreditation and Medicare Conditions and Survey Requirements

    We compared ACHC's ESRD facility accreditation requirements and 
survey process with the Medicare CoPs of parts 494, and the survey and 
certification process requirements of parts 488 and 489. Our review and 
evaluation of ACHC's ESRD facility accreditation application, which 
were conducted as described in section III. of this final notice, 
yielded the following areas where, as of the date of this final notice, 
ACHC has completed revising its standards and certification processes 
in order to--
     Meet the standard's requirements of all of the following 
regulations:
    ++ Section 494.30(b)(3)(x), to clarify and address the contingency 
plans for staff who are not fully vaccinated for COVID-19.
    ++ Section 494.60(d)(1), to address dialysis facilities that do not 
provide one or more exits to the outside must comply with Life Safety 
Code (NFPA 101).
    ++ Section 494.60(d)(4), to clarify specific Life Safety Code 
provisions that may be waived, only if the waiver will not adversely 
affect the health and safety of the patients.
    ++ Section 494.60(d)(5), to clarify that no dialysis facility may 
operate in a building adjacent to an industrial high hazard area.
    In addition to the standards review, CMS also reviewed ACHC's 
comparable survey processes, which were conducted as described in 
section III. of this final notice, and yielded the

[[Page 16983]]

following areas where, as of the date of this final notice, ACHC has 
completed revising its survey processes in order to demonstrate that it 
uses survey processes that are comparable to state survey agency 
processes by:
    ++ Revising the compliant policies and processes to align with the 
State Operations Manual, Chapter 5 guidance. In particular, the 
Administrative Review Offsite Investigation process to align with the 
triage process to track and trend for potential focus areas during the 
next onsite survey or complete an onsite complaint investigation.
    ++ Clarifying the quantifying data surrounding equipment and 
maintenance logs, specifically the equipment review. The survey reports 
or notes need to identify the number of logs reviewed, date or 
timeframes.
    ++ Providing surveyor training on documentation reviews and the 
process for verifying the completeness of the facility request.
    ++ Reinforcing and providing education to facility surveyors to 
request Dialysis Facility Reports, the reports provide aggregate data 
regarding laboratory values, demographic information, mortality rates, 
hospitalizations, infections, etc., which may assist the surveyors 
during the review of patient medical records.
    ++ Developing additional surveyor training for verifying all 
elements required for the CMS emergency preparedness requirements.

B. Term of Approval

    Based on our review and observations described in section III. and 
section V. of this final notice, we approve ACHC as a national 
accreditation organization for ESRD facilities that request 
participation in the Medicare program. The decision announced in this 
final notice is effective April 11, 2023 through April 11, 2029 (6 
years). In accordance with Sec.  488.5(e)(2)(i) the term of the 
approval will not exceed 6 years.
    While ACHC has taken actions based on the findings annotated in 
section V.A., of this final notice, (Differences Between ACHC's 
Standards and Requirements for Accreditation and Medicare Conditions 
and Survey Requirements) as authorized under Sec.  488.8, we will 
continue ongoing review of ACHC's ESRD survey substance and processes. 
In keeping with CMS's initiative to increase AO oversight broadly, and 
ensure that our requested revisions by ACHC are completed, CMS expects 
more frequent review of ACHC's activities in the future.

VI. Collection of Information Requirements

    This document does not impose information collection requirements, 
that is, reporting, recordkeeping or third-party disclosure 
requirements. Consequently, there is no need for review by the Office 
of Management and Budget under the authority of the Paperwork Reduction 
Act of 1995 (44 U.S.C. 3501 et seq.)
    The Administrator of the Centers for Medicare & Medicaid Services 
(CMS), Chiquita Brooks-LaSure, having reviewed and approved this 
document, authorizes Evell J.Barco Holland, who is the Federal Register 
Liaison, to electronically sign this document for purposes of 
publication in the Federal Register.

    Dated: March 15, 2023.
Evell J. Barco Holland,
Federal Register Liaison, Center for Medicare & Medicaid Services.
[FR Doc. 2023-05761 Filed 3-20-23; 8:45 am]
BILLING CODE 4120-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.